Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience

Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation

(2016) Heidi D. Nelson et al.   ANNALS OF INTERNAL MEDICINE

Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review

(2016) Johanna Ringwald et al.   Journal of Genetic Counseling

Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?

(2015) Matthew B. Yurgelun et al.   JOURNAL OF CLINICAL ONCOLOGY

Facilitators and Challenges in Psychosocial Adaptation to Being at Increased Familial Risk of Breast Cancer

(2015) Louise Heiniger et al.   Journal of Genetic Counseling

Experiences of Women Who Underwent Predictive BRCA 1/2 Mutation Testing Before the Age of 30

(2015) Kate Brunstrom et al.   Journal of Genetic Counseling

Population genetic testing for cancer susceptibility: founder mutations to genomes

(2015) William D. Foulkes et al.   Nature Reviews Clinical Oncology

Genetic Testing forBRCAMutations Today and Tomorrow—About the ABOUT Study

(2015) Steven Narod   JAMA Oncology

Utilization and Outcomes ofBRCAGenetic Testing and Counseling in a National Commercially Insured Population

(2015) Joanne Armstrong et al.   JAMA Oncology

Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry

(2014) Eric Rosenthal et al.   BREAST CANCER RESEARCH AND TREATMENT

Population-Based Screening forBRCA1andBRCA2

(2014) Mary-Claire King et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial

(2014) Ranjit Manchanda et al.   JNCI-Journal of the National Cancer Institute

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing

(2014) Ranjit Manchanda et al.   JNCI-Journal of the National Cancer Institute

Population-based screening for breast and ovarian cancer risk due toBRCA1andBRCA2

(2014) Efrat Gabai-Kapara et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Psychological Distress after a Positive Fecal Occult Blood Test Result among Members of an Integrated Healthcare Delivery System

(2013) S. S. Laing et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

(2013) Robert C. Green et al.   GENETICS IN MEDICINE

Clinicians' Attitudes toward General Screening of the Ashkenazi-Jewish Population for Prevalent Founder BRCA1/2 and LRRK2 Mutations

(2013) S. Shkedi-Rafid et al.   Public Health Genomics

Dealing with the unexpected: consumer responses to direct-accessBRCAmutation testing

(2013) Uta Francke et al.   PeerJ

Long-Term Psychosocial Outcomes of BRCA1/BRCA2 Testing: Differences across Affected Status and Risk-Reducing Surgery Choice

(2012) K. D. Graves et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women

(2009) Kelly A. Metcalfe et al.   JOURNAL OF CLINICAL ONCOLOGY

Living With Genetic Test Results for Hereditary Breast and Ovarian Cancer

(2009) Rebekah Hamilton et al.   JOURNAL OF NURSING SCHOLARSHIP

Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk

(2008) Claire E. Wakefield et al.   CANCER